To the EditorSynthetic cannabinoid receptor agonists (SCRA’s) encompass a diverse class of direct endogenous cannabinoid receptor agonists [1] with various clinical effects including: altered menta...
No takes yet. Share an insight, caveat, or question.
Arens et al. (2018) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: